Allianz Asset Management
CNTA

Allianz Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Allianz Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,900
Closed -$274K – 2157
2026
Q1 		$274K Buy
+6,900
New +$176K ﹤0.01% 1911

Allianz Asset Management's CNTA Position: Q2 2026 in Review

Allianz Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,900 shares — an estimated $274K sold.

Allianz Asset Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $274K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • Allianz Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Allianz Asset Management sold 6,900 Centessa Pharmaceuticals shares in Q2 2026, an estimated $274K.
  • Allianz Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Allianz Asset Management's Centessa Pharmaceuticals position peaked at $274K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.